hedera_helix_l
Unterschiede
Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
Beide Seiten der vorigen RevisionVorhergehende ÜberarbeitungNächste Überarbeitung | Vorhergehende Überarbeitung | ||
hedera_helix_l [2015/03/15 18:34] – andreas | hedera_helix_l [2024/12/27 09:37] (aktuell) – andreas | ||
---|---|---|---|
Zeile 9: | Zeile 9: | ||
[[http:// | [[http:// | ||
- | " | + | " |
α-Hederin amounts in younger flowering branch leaves were remarkably higher than in older ones, in B2, [it] was found in 1.62% whereas in B1 it was only 0.18%. Non-flowering branch leaves (B3) contained hederacoside C in 6.53%, which was found in flowering branch leaves (B1) in 4.72% amount, α-hederin was not detected in B3." \\ | α-Hederin amounts in younger flowering branch leaves were remarkably higher than in older ones, in B2, [it] was found in 1.62% whereas in B1 it was only 0.18%. Non-flowering branch leaves (B3) contained hederacoside C in 6.53%, which was found in flowering branch leaves (B1) in 4.72% amount, α-hederin was not detected in B3." \\ | ||
[HPLC profiling and quantification of active principles in leaves of Hedera helix L., Demirci, B., Goppel, M., Demirci, F., Franz, G., Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.59(10), 2004, 770-774] | [HPLC profiling and quantification of active principles in leaves of Hedera helix L., Demirci, B., Goppel, M., Demirci, F., Franz, G., Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.59(10), 2004, 770-774] | ||
Zeile 16: | Zeile 16: | ||
During a 16-year period from May 1993 to May 2009, 127 persons, including controls, were patch tested with falcarinol and 10 tested positive." | During a 16-year period from May 1993 to May 2009, 127 persons, including controls, were patch tested with falcarinol and 10 tested positive." | ||
[Dermatitis from common ivy (Hedera helix L. subsp. helix) in Europe: past, present, and future., Paulsen, E., Christensen, | [Dermatitis from common ivy (Hedera helix L. subsp. helix) in Europe: past, present, and future., Paulsen, E., Christensen, | ||
+ | |||
+ | {{: | ||
+ | |||
+ | " | ||
+ | [Pre-treatment with α-hederin increases β-adrenoceptor mediated relaxation of airway smooth muscle., Wolf, A., Gosens, R., Meurs, H., Häberlein, H., Phytomedicine, | ||
Oral administration of hederacoside C to rats results in a low absolute oral bioavailability of 0.118–0.250%. This extremely bioavailabilty may be due to poor absorption from the gastrointestinal tract and/or its decomposition therein. \\ | Oral administration of hederacoside C to rats results in a low absolute oral bioavailability of 0.118–0.250%. This extremely bioavailabilty may be due to poor absorption from the gastrointestinal tract and/or its decomposition therein. \\ | ||
Zeile 24: | Zeile 29: | ||
[[http:// | [[http:// | ||
- | "The effect of ivy leaves dry extract is based on its secretolytical and broncholytical properties. The main active compounds are saponins (Cioacá et al., 1978, Trute et al., 1997 and Bedir et al., 2000), especially | + | "The effect of ivy leaves dry extract is based on its secretolytical and broncholytical properties. The main active compounds are saponins (Cioacá et al., 1978, Trute et al., 1997 and Bedir et al., 2000), especially |
... children with mild uncontrolled asthma despite regular inhaled corticosteroid therapy might benefit from an additional therapy with ivy leaves dry extract. However, further studies are needed." | ... children with mild uncontrolled asthma despite regular inhaled corticosteroid therapy might benefit from an additional therapy with ivy leaves dry extract. However, further studies are needed." | ||
[Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma., Zeil, S., Schwanebeck, | [Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma., Zeil, S., Schwanebeck, | ||
[[http:// | [[http:// | ||
- | {{: | + | "The bronchospasmolytic and secretolytic effects of ivy leaves dry extracts can be explained by an increased β2-adrenergic responsiveness of the bronchi. Recently, it was shown that α-hederin inhibits the internalization of β2-adrenergic receptors (ß2AR) under stimulating conditions. α-Hederin pretreated alveolar type II cells and human airway smooth muscle cells revealed an increased ß2AR binding and an elevated intracellular cAMP level, respectively...\\ |
- | Lindman, C.A.M., Bilder ur Nordens Flora, vol.2, t.249 (1922-1926) \\ | + | In order to identify whether additional compounds also mediate an increased β2-adrenergic responsiveness, |
- | [[http://plantgenera.org/species.php? | + | [A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the β 2-adrenergic responsiveness of human airway smooth muscle cells., Greunke, C., Hage-Hülsmann, |
+ | [[http:// | ||
+ | |||
+ | "... hederagenin has been shown to possess anti-nociceptive and anti-inflammatory properties in mice, and ivy extracts are commonly used in natural medicine to treat rheumatoid arthritis... [hederagenin is] a novel and selective antagonist at the NPFFR1. Through comprehensive analysis, its binding mode at the NPFFR1 and critical residues that contribute to the selectivity of the antagonist over NPFFR2 have been determined." | ||
+ | [Lentschat, Hannah, et al. " | ||
+ | |||
+ | {{: | ||
+ | [[http:// | ||
+ | |||
+ | {{: | ||
+ | Hedera helix leaves | ||
- | {{: |
hedera_helix_l.1426444490.txt.gz · Zuletzt geändert: 2015/03/15 18:34 von andreas